Deciding two connected writ petitions arising from a common Industrial Tribunal Award, the Delhi High Court set aside the Tribunal's direction granting hotel workmen a further…
AstraZeneca to Invest $2.5bn in China After Scandal
Update / Judgement Date
21 Mar 2025
Source
Author
Team — WCP Legal Desk
Reading Time
1 min read
AstraZeneca announced a $2.5 billion investment in research and development and manufacturing in Beijing. This move comes amidst a strategy to overcome a scandal involving the detention of a high-ranking executive over illegal drug sales practices.